My Companies
Notification
Account
Log Out
Login
Anupam Rasayan and Mates Visa completed acquisition of 47.95% (5.09cr shares, including 1,669 via open offer) and became promoters Sept 28. MD S.N. Kamath resigned on SPA completion; three non-executive directors appointed, postal ballot sought. Context: completes pending control transition.
Bliss GVS Pharma Promoters Pledge 47.95 Percent Stake To Catalyst
Bliss GVS Pharma Board Approves Two ESOP Schemes For 73.5 Lakh Shares
Bliss GVS Pharma Completes 34.82% Stake Transfer To Anupam Rasayan
Bliss GVS Pharma Completes 47.95% Control Transfer To Anupam Rasayan
Bliss GVS Pharma Appoints Rahul Adakmol As CEO, Narsimha Kamath Steps Down